Objective To estimate the comparative clinical efficacy and acceptability of non-surgical
brain stimulation for the acute treatment of major depressive episodes in adults. Design …

A group of European experts was commissioned to establish guidelines on the therapeutic
use of repetitive transcranial magnetic stimulation (rTMS) from evidence published up until …

Importance The placebo effect in depression clinical trials is a substantial factor associated
with failure to establish efficacy of novel and repurposed treatments. However, the …

Background Although several studies indicate that placebo response is large to
antidepressant pharmacotherapy in major depressive disorder (MDD), no updated meta …

This opinion review summarizes current knowledge in the field and addresses the future
direction of rTMS treatment in MDD, facilitating the establishment of this clinical intervention …

Background Intermittent theta burst stimulation (iTBS) is a newer form of repetitive
transcranial magnetic stimulation (rTMS) for patients with treatment resistant depression …

Background: Approximately 35% of people with depression do not respond to 2 courses of
antidepressant medications of adequate dosage, and treatment-resistant depression (TRD) …

Repetitive transcranial magnetic stimulation (rTMS) is an effective and evidence-based
therapy for treatment-resistant major depressive disorder. A conventional course of rTMS …

Background Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive, effective,
and FDA-approved brain stimulation method. However, rTMS parameter selection remains …

This meta-analysis investigated placebo responses in repetitive transcranial magnetic
stimulation treatment for depression, an area with limited systematic analysis. The initial …